No Causal Association between Angiotensin-Converting Enzyme Inhibitors and Skin Fibrosis Risk: Evidence from Mendelian Randomization
Authors:
- 13 January 2025
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (7) , 1808-1810.e3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Identifying Potential Drug Targets for Keloid: A Mendelian Randomization StudyJournal of Investigative Dermatology, 2024
- Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principleseGastroenterology, 2024
- ScarsNature Reviews Disease Primers, 2023
- Targeting the Angiotensin Pathway in the Treatment of Cutaneous Fibrosis: A Systematic ReviewJID Innovations, 2023
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin systemAmerican Journal of Physiology-Cell Physiology, 2023
- Current Advances in Hypertrophic Scar and Keloid ManagementSeminars in Plastic Surgery, 2021
- The renin‐angiotensin system in cutaneous hypertrophic scar and keloid formationExperimental Dermatology, 2020
- The source of ACE during scar formation is from both bone marrow and skin tissueThe FASEB Journal, 2018
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median EstimatorGenetic Epidemiology, 2016
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013